VEITHsymposium - Vascular and Endovascular Issues, Techniques and Horizons ('06)
Session I: HEMODIALYSIS ACCESS
| Preventing Contrast-Induced Nephropathy: A New Tool For An Old Problem | John H. Rundback |
| Endovascular Management Of The Non-Maturing Fistula | Thomas M. Vesely |
| Percutaneous Management Of The Thrombosed Fistula | Mark J. Sands |
| Percutaneous Management Of The Thrombosed Graft | Jacob Cynamon |
| Management Of Peripheral Venous Stenoses: High Pressure Balloons, Cutting Balloons, Stents Or Stent-Grafts? | Ziv J. Haskal |
| Management Of Central Venous Stenoses/Occlusions | Bart L. Dolmatch |
| Use Of Stent-Grafts For The Management Of Hemodialysis Graft Related Pseudoaneurysms | Thomas M. Vesely |
| Utility Of The Angioflow Catheter | Mark J. Sands |
| New Developments In Hemodialysis Catheter Technology | Thomas M. Vesely |
| Outpatient Intervention: Not Just For Dialysis And Venous Intervention | William H. Julien |
| Panel Discussion |
Session II: AV FISTULAS, TRANSPOSITIONS AND GRAFTS
| Why We Need A Vascular Access Society | A. Frederick Schild |
| 2006 K/DOQI Guideline Changes | Mitchell Henry |
| Surgical Methods To Maximize Fistula Creation | Surendra Shenoy |
| Surgical Management Of The Non-Maturing AV Fistula | John R. Ross |
| Outcomes Of Transposed AV Fistulas | Alik Farber |
| Vascular Access Centers | James F. McGuckin |
| Panel Discussion | |
| Keynote Address: Early History Of AV Access For Hemodialysis | James E. Cimino |
Session III: MISCELLANEOUS TOPICS IN VASCULAR ACCESS
| Use Of Anastomotic Devices For Hemodialysis Access | Duane Blatter |
| Molecular Therapy For Hemodialysis Access | Jeffrey H. Lawson |
| Ischemic Complications Of Vascular Access | Samuel Eric Wilson |
| Educating Trainees In Vascular Access | Earl Schuman |
| Coding For Hemodialysis Access Surgery And Interventions | Sean P. Roddy |
| New Graft Materials For Hemodialysis Access | Marc H. Glickman |
| Panel Discussion |
Session IV: OPICS OF INTEREST TO INTERVENTIONALISTS AND VASCULAR SURGEONS
| Is Carotid Stenting (CAS) Really Contraindicated In Patients Over 80 Years Of Age? Why Is This So? | Michel S. Makaroun |
| Technical Tips For Performing CAS Safely: Which Patients Should Get Endarterectomy (CEA) Based On Angiographic And IVUS Evaluation Of Plaque Morphology? | Mark H. Wholey |
| Evolution Of Proximal Occlusion Embolic Protection Devices: Relative And Absolute Indications And Contraindications | Juan C. Parodi |
| Are Endovascular Procedures Feasible In Infants And Children? What Precautions Or Special Instrumentation Are Needed? | Michael B. Silva |
| Results Of Celiac And Mesenteric Stenting: Technical Tips And High Recurrence Rates | Jos C. van den Berg |
| Debate: Open AAA Repair Still Has A Major Role In Good Risk Young Patients | Robert B. Rutherford |
| Debate: All Good Risk AAA Patients With Suitable Anatomy Should Be Treated With EVAR | Edward B. Diethrich |
| Panel Discussion |
Session V: MORE TOPICS OF INTEREST TO INTERVENTIONALISTS AND VASCULAR SURGEONS
| Debate: Neck Enlargement After EVAR Is Common And Has Dire Consequences | Piergiorgio Cao |
| Debate: Neck Enlargement After EVAR Is Rare And Benign | James May |
| Technique And Importance Of Duplex Surveillance After SFA Stenting: Does It Make A Difference? | Dennis F. Bandyk |
| One-Year Results Of The FAST Trial For The Treatment Of SFA Disease | Hans Krankenberg |
| Role Of Cutting Balloons For De Novo And Recurrent Lesions | Peter A. Schneider |
| Panel Discussion |
Session VI: NEW HORIZONS AND OPPORTUNITIES FOR CARDIAC SURGEONS
| Endovascular Approaches To Mitral Valve Disease | Ted Feldman |
| Endovascular Pulmonic Valve Replacement | Philipp Bonhoeffer |
| Functional Replacement For Tricuspid Insufficiency: An Endovascular Approach | Roy K. Greenberg |
| Experience With Percutaneous Aortic Valve Replacement: Future Potential | Martin B. Leon |
| Implications Of The Aortic Valve On Endovascular Repairs Of The Ascending Aorta | Timothy A.M. Chuter |
| Hybrid (Open/Endo) Approaches For Repair Of Ascending And Arch Aneurysms | Bruce Lytle |
| Debate: Endovascular Treatment Of Adult Coarctation And Its Complications: The Best Treatment For Most Patients | Christoph A. Nienaber |
| Debate: Current Status Of Treatment For Adult Coarctation: Open Surgery Is Still The Best Treatment For Most Patients | Joseph E. Bavaria |
| Panel Discussion |
Session VII: SUPERFICIAL FEMORAL ARTERY (SFA) AND CRURAL ARTERY TREATMENT: STATE-OF-THE-ART AND NEW ADJUNCTS
| Natural History Of Patients With Arterial Insufficiency And Non-Healing Ulcers Treated Conservatively: How Does It Impact On Limb Salvage Results With Aggressive New Endo-Interventions And Are We Being Fooled Into Over-Treating? | Blair A. Keagy |
| Outcomes Of Infrainguinal Intervention: Beyond The Hype And Baloney - What Really Works And What Does Not? | Alan T. Hirsch |
| PTA vs. Stenting Of The SFA: Results Of The Resilient Randomized Trial | Barry T. Katzen |
| How To Avoid Fractures In SFA Stents And Will It Improve Results: Are Absorbable Stents The Answer? | Giancarlo Biamino |
| Role Of SFA Stents In 2006: How Well Do They Work? | Mark W. Mewissen |
| Do We Have The Right Stents For Femoropopliteal Lesions And 2-3 Year Results Of A Randomized Trial Comparing Absorbable Metal Stents To PTA Alone In Crural Arteries? | Marc Bosiers |
| 3 Year Trial Results Of Zilver Nitinol Stents For Long SFA Lesions (TASC C And D) | Marcelo Ferreira |
| Update On The Value And Limitations Of The Silverhawk Rotational Atherectomy Device For Treatment Of Infrainguinal Disease | Venkatesh G. Ramaiah |
| Midterm Results Of Rotational Atherectomy In Patients With TASC C Lesions Treated For Critical Ischemia | David J. Minion |
| Role Of Lasers In The Treatment Of Lower Extremity Occlusive Disease: Is There A Place After All? | John R. Laird |
| Panel Discussion |
Session VIII: CRITICAL LOOK AT CAROTID STENTING (CAS)
| Debate: Carotid Interventions Are Justified In High Risk Asymptomatic Patients: Of Course They Are | Frank J. Criado |
| Debate: Why Interventions (CAS And CEA) Are Rarely Justified And Indicated In High Risk Asymptomatic Patients | Geoffrey L. Gilling-Smith |
| Is It Justified And Ethical To Perform CAS In Asymptomatic Patients? Will We Ever Know? | Alison Halliday |
| The Asymptomatic Carotid Trials: How Can The Results Be Interpreted So Differently And Should Asymptomatic Patients Really Be Treated? | A. Ross Naylor |
| In Asymptomatic Patients, What Is A High Risk Plaque If We Intervene? If We Treat Conservatively? What Should We Do? | Giorgio M. Biasi |
| Embolic Protection Devices In CAS Remain Unproven And Are Much Ado About Nothing | Emmanuel M. Houdart |
| Randomized Prospective Trial Of Embolic Protection Devices In CAS | Michel S. Makaroun |
| CAS vs. CEA In Symptomatic Carotid Stenosis Patients: Early Results Of The French Randomized Study (EVA-3S) | Jean-Pierre Becquemin |
| A New Technique To Reduce Guidewire Manipulation During Carotid Artery Stenting: The Superficial Temporal Artery Approach | Martin Malina |
| Panel Discussion |
Session IX: NEW DEVELOPMENTS IN EVAR
| Debate: Fenestrated Grafts For Short-Necked AAAs Are Time Consuming, Costly And Unnecessary | Jacob Buth |
| Debate: Fenestrated Grafts For Short-Necked AAAs Are Easy, Effective And The Way To Go | Roy K. Greenberg |
| Does The Graft Make A Difference In EVAR? Which Graft Should Be Used To Deal With Short Necks? With Angulated Necks? | Dieter Raithel |
| Can EVAR Be Used Successfully In Patients With <15 mm Necks? | Neal S. Cayne |
| Why Do Results With EVAR For Ruptured AAAs Vary? Technical Tips, Adjuncts And Strategies To Improve These Results | Frank J. Veith |
| Solving The Problem Of Abdominal Compartment Syndrome After EVAR For Ruptured AAAs: Detection And Treatment | Mario Lachat |
| Evolution Of Optimal Methods To Follow Patients After EVAR: Several Myths Need To Be Dispelled | Jan D. Blankensteijn |
| Panel Discussion |
Session X: OTHER TOPICS OF INTEREST TO INTERVENTIONALISTS AND VASCULAR SURGEONS
| The Real Truth About Endografts For Popliteal Aneurysm Disease Based On An 8-Year Experience With More Than 70 Cases: Indications, Contraindications And Complications | Eric L.G. Verhoeven |
| The Pioneer, Frontrunner Or Outback Catheter Are Necessary Adjuncts For Crossing Occlusive Lesions | Mark W. Mewissen |
| Simple Techniques For Crossing Total Occlusions Of The Iliac, Femoropopliteal And Crural Arteries Without Special Devices | Ali Amin |
| Subintimal Angioplasty Of Long Occlusive Lesions Of The SFA And Tibial Arteries: Technical Tips And Midterm Results | Joseph L. Mills |
| Technical Tips, Tricks And Adjuncts To Improve Endovascular Treatment Of Leg Artery Lesions Causing Critical Ischemia | Max Amor |
| Debate: The SAPPHIRE And CAPTURE Trials Establish The Basis For Widespread Use Of Carotid Stenting (CAS) | Jay S. Yadav |
| Debate: The SAPPHIRE And CAPTURE Trials Are Flawed And Should Have Minimal Impact On The Expanded Use Of CAS | Peter R.F. Bell |
| CAS vs. CEA In Symptomatic Carotid Stenosis Patients: Results Of The German Randomized Trial (The SPACE Trial) | Hans-Henning Eckstein |
| Panel Discussion |
Session XI:PREVENTION AND MANAGEMENT OF COMPLICATIONS OF ENDOVASCULAR TREATMENTS
| What Should Be Done When A Stroke Occurs During Or After CAS? | Claudio Schonholz |
| How To Prevent Strokes During CAS: It’s The Details That Count | Juan C. Parodi |
| Is There A Role For Embolic Protection During Femoropopliteal Interventions? How Should It Be Done? | Michael H. Wholey |
| Update On Approved And Unapproved Uses Of The RENU Proximal Extension Device: Indications, Precautions And Results | Samuel R. Money |
| Pros And Cons Of Embolic Protection During Renal PTA And Stenting | Thomas A. Sos |
| Panel Discussion |
Session XII: UPDATES AND NEW CONCEPTS IN VASCULAR DISEASE AND ITS TREATMENT
| Radiation Danger To Surgeons And Interventionists During Endovascular Procedures Is Greater Than Previously Thought: What Can Be Done About It? | Gary M. Ansel |
| What Improvements Make Simulators More Useful For Endovascular Training In Interventions? | James R. Duncan |
| Optimal Agents For Embolic Therapy: New Developments | Götz M. Richter |
| The Next Generation Of "Safer" Drug-Eluting Stents: What Does The Future Hold? | Martin B. Leon |
| Highlights Of 2006 Consensus Statement On Prevention And Treatment Of Venous Thromboembolism | Andrew N. Nicolaides |
| Panel Discussion | |
| What Is The Best Treatment For Iliac Occlusive Disease? Which Lesion Should Be Ballooned, Which Stented, Which Bypassed And Which Left Alone? | Peter G. Kalman |
| Ultrasound Accelerated Lysis: Technique And Multicenter Experience | Thomas O. McNamara |
| A Stent With A Biological Covering (Peritoneum): Experimental And Early Clinical Evaluation Of A Potentially Better Device | Timur P. Sarac |
| Is Balloon Angioplasty Of Perianastomotic Stenoses Of Failing Leg Bypasses Worthwhile? | Keith D. Calligaro |
| A New Drug To Help Smokers Quit: The Role of VARENICLINE | Richard D. Hurt |
| Panel Discussion |
Session XIII ISVS AWARD PAPERS
| The Development And Implementation Of Endovascular Capabilities In Wartime: A Report From The 332nd EMDG / Air Force Theater Hospital | Major Andrew N. Bowser |
| The Volume-Outcome Relationship In Abdominal Aortic Aneurysm Surgery | Peter J.E. Holt |
| Carotid Angioplasty And Stenting For Post Endarterectomy Stenosis: Long-Term Follow -Up | Gerrit J. de Borst |
| Panel Discussion |
Session XIV: FOCUS ON NEW OR IMPROVED TECHNOLOGY
| Design Of A Non-High Risk CAS Trial | Kenneth Ouriel |
| Endovascular Management Of Iliac Artery (TASC C And D) Lesions: When Should They Be Treated By PTA And Stenting And When By Open Bypass? | Sean P. Lyden |
| Cryo Balloon Angioplasty Broadens The Role Of Primary PTA And Reduces The Need For Stenting In Complex SFA Lesions (TASC C And D) | Karl A. Illig |
| Experimental Basis For Cryoplasty: Why Does It Work? | Bauer E. Sumpio |
| Open Cell Versus Closed Cell Carotid Stent Design: Indications, Advantages And Limitations Of Each | Mark H. Wholey |
| Panel Discussion |
Session XV: PROGRESS IN THE TREATMENT OF THORACIC AND THORACOABDOMINAL ANEURYSMS
| Update On The US Trial With The TX2 Thoracic Endograft | Jon S. Matsumura |
| Ten-Year Experience With Thoracic Endografts: Lessons Learned | Ludger Sunder-Plassmann |
| Will We Be Able To Treat Type A Dissections With Endografts? | Edward B. Diethrich |
| Present And Future Role Of Endografts For The Treatment Of Dissecting Aneurysms | Michael D. Dake |
| Top 5 Reasons Why Thoracic Endografting Is More Complex And Dangerous Than Endograft Repair Of AAAs | Frank J. Criado |
| Current Limitations Of Thoracic Aortic Endografts | Martin Malina |
| The Truth About Thoracic Endografts: Are They All They Are Cracked Up To Be? | Jean-Pierre Becquemin |
| Panel Discussion | |
| Evolution Of Fenestrated And Branched Endograft Devices: Will They Allow Endovascular Treatment Of All Aneurysms? | David E. Hartley |
| Late Results With Fenestrated And Branched Endografts For Pararenal And Thoracoabdominal Aneurysms | John L. Anderson |
| Lessons Learned From A 5-Year Experience With Fenestrated Endografts | Michael Lawrence-Brown |
| New Hybrid Technique (Endo/Open) For Complex Aneurysms Requiring Branched Grafts | Mario Lachat |
| Open Surgical Repair Of Descending Thoracic Aneurysms In The Endovascular Era: A 10-Year Experience | Edouard Kieffer |
| What Patients Will Never Be Suitable For Aortic Endograft Treatment? | Hazim J. Safi |
| Panel Discussion |
Session XVI: NEW DEVELOPMENTS IN THE TREATMENT OF LOWER EXTREMITY ARTERIAL DISEASE BY OPEN SURGERY
| Lower Extremity Bypass Grafting Improves Quality Of Life: Results Of An 83-Center Study From The PREVENT Trial | Gregory L. Moneta |
| Duplex Guided Suction Thromboembolectomy – Techniques And Results: Is It A Better Way? | Enrico Ascher |
| Debate: Minimally Invasive Vein Harvest Is Better For Lower Extremity Bypasses | Peter Gloviczki |
| Debate: Compromised Bypass Outcomes After Minimal Incision Vein Harvest: It May Not Be A Better Way | Thomas E. Brothers |
| Is There A Role For Endografts In The Treatment Of Long Segment SFA Occlusion? | Thomas F. Panetta |
| Femoropopliteal Bypass Is Still The Gold Standard For SFA Disease | John E. Connolly |
| Debate: Have Distal Anastomotic Vein Patches/Cuffs Or Distally Hooded Grafts Proven To Be Better Than Standard Prosthetic Grafts To Infrapopliteal Arteries? | Paul J. Gagne |
| Debate: All This Stuff About Patches, Cuffs And Hoods Is Nonsense | Evan C. Lipsitz |
| Improved 3-Year Patency Of Heparin Bonded PTFE (Propaten™) Grafts For Leg Bypasses | Patrick Peeters |
| What Factors Affect Lower Extremity Graft Failure? Can Any Be Modified? | Anton N. Sidawy |
| Management Of Popliteal Artery Injuries In The War On Terrorism: Can Limbs Be Saved And How? | David L. Gillespie |
| A New Swirl Design For Prosthetic Bypass Grafts: Reasons Why This May Be Better Than Existing Grafts: Experimental And Early Clinical Results | Nicholas J.W. Cheshire |
Session XVII: ADVANCES IN MEDICAL TREATMENTS OR TREATMENTS OF MEDICAL PROBLEMS IN VASCULAR PATIENTS
| Apo A-1 Milano Analogues, Torceptrapib, D-4F And Other HDL Raising Drugs: How Do They Work? | Russell H. Samson |
| Will Apo A-1 Milano Analogues And Other Medications Promote Clearing Of Atherosclerotic Plaque? When Will They Be Available? | Stephen Nicholls |
| Implantable Carotid Sinus Electrical Stimulation With The Rheos System For Treatment Of Drug Resistant Hypertension: Early Clinical Demonstration Of Safety And Effectiveness From A Multicenter Trial | Jürg Schmidli |
| Adjunctive Medical Therapies In Lower Extremity Bypass Surgery | Michael S. Conte |
| Hemodynamic Changes During CAS: Their Prevention Prevents Stroke And Mandates An Anesthesiologist For The Procedure | Marc R.H.M. van Sambeek |
| Preoperative Studies And Appropriate Coronary Revascularization Are Not Worthwhile In Vascular Surgery Patients With And Without Coronary Artery Disease: Based On A Large Multicenter Randomized Trial | Joseph H. Rapp |
| Myths And Facts Regarding The Expanding Global Epidemic Of Cardiovascular Disease: What Can Be Done To Stop It? | Allan D. Callow |
| Panel Discussion |
Session XVIII: MORE ABOUT ANEURYSMS AND THEIR TREATMENT
| Accepted Indications For Thoracic Endografts In France: Are These Reasonable In View Of Current Knowledge Worldwide? | Patrice F. Bergeron |
| Thoracic Aortic Dissections: Choosing The Right Techniques For Evaluation And Treatment | David M. Williams |
| How To Deal With Mobile Plaque In The Thoracic Aorta: Diagnosis, Prognosis And Treatment | Lars G. Svensson |
| Experience With A New Device (Proximal Covered Stent/Distal Open Stent) For Treatment Of Type B Aortic Dissections | Joseph V. Lombardi |
| Technical Tips For Stent-Graft Treatment Of Aortic Dissections: Important Precautions And Optimal Imaging | Burkhart Zipfel |
| Device Problems In The Curvature Zone Of The Upper Thoracic Aorta: How Can They Be Prevented? | Geoffrey H. White |
| What Is Happening With EVAR In Belgium? On What Basis Is There Difficulty With Reimbursement For EVAR? What Were The Findings And Flaws In The Belgian EUROSTAR Data? | Patrick Peeters |
| Percutaneous AAA Repair: Technical Improvements, Precautions And Contraindications: Is It For Every Surgeon? For Every Patient? | Zvonimir Krajcer |
| Panel Discussion |
Session XIX: PROGRESS IN VASCULAR IMAGING
| Can CT Coronary Arteriography Now Replace Catheter Contrast Arteriography? If We Can Image The Coronaries We Can Image Anything | Geoffrey D. Rubin |
| Dynamic Cine MRA And CT To Evaluate AAA Morphology Before And After EVAR: Will It Obviate The Need For Sac Pressure Measurements And Importance With Branched Grafts To The Renal Arteries? | Hence J.M. Verhagen |
| Technique Of Virtual Histology Intravascular Ultrasound: Its Role In Assessing Plaque Morphology And Influencing Patient Selection And Management With Carotid Lesions | Donald B. Reid |
| Carotid Plaque Analysis By Ultrasound Activity Index: What Role Should It Play In Determining Which Patients Need Intervention And What That Intervention Should Be? | Jose Fernandes e Fernandes |
| Does Duplex Carotid Evaluation Lead To Over-Utilization Of Prophylactic Carotid Interventions? | Gregory L. Moneta |
| How To Credential Vascular Surgeons Adequately For Reading Vascular Lab Studies | R. Eugene Zierler |
| Panel Discussion |
Session XX: INTERESTING NEW DEVELOPMENTS IN DIALYSIS ACCESS AND VASCULAR TREATMENTS
| Should All ESRD Patients Have An AV Fistula: A Retrospective Review Of 1,700 Consecutive Patients | A. Frederick Schild |
| The Use Of The U-Clip In Hemodialysis Access Surgery | Marc H. Glickman |
| How To Best Revise Failing Venous Bypass Grafts: Which Is Better, Venous Patches Or Interposition Grafts? | R. Clement Darling III |
| New Technology For Direct Intravascular Delivery Of Nitric Oxide As A Therapeutic Agent: Experimental And Early Pre-Clinical Experience | Barry T. Katzen |
| Panel Discussion |
Session XXI: NEW DEVELOPMENTS IN VENOUS DISEASE AND ITS TREATMENT
| The Future Of Venous Disease And Its Treatment | Bo G. Eklof |
| Present Role Of IVC Filter Placement In Patients Undergoing Open And Laparoscopic Gastric Bypass: Techniques, Indications And Effectiveness | Nicholas J. Gargiulo |
| Temporary IVC Filters: Lessons Learned After 100 Retrievals: What Is The Future? | David Rosenthal |
| DVT – When To Treat, When Not To Treat: Use Of Lysis And Mechanical Thrombectomy | Cynthia K. Shortell |
| Role Of New Biomarkers In The Diagnosis And Management Of DVT: Do They Really Help? | Thomas W. Wakefield |
| Update On Endovenous Valve Replacement: Long-Term Results | Dusan Pavcnik |
| Dangerous Venous Crossings By Arteries: Location, Pathology And Optimal Treatment | J. Leonel Villavicencio |
| PTA Without Stenting Is Effective For Central Brachiocephalic Vein Stenoses: When Are Stents Indicated? | Samuel S. Ahn |
| Panel Discussion | |
| Treatment Of Venous Ulcers By Excision And Split Thickness | Kevin G. Burnand |
| Saphenous Nerve Injury With Vein Surgery: Incidence, Diagnosis, Impact, Prevention And Treatment | Michael C. Dalsing |
| Trials, Tribulations And Advantages Of Opening A Freestanding Outpatient Vein Center | Richard A. Baum |
| Evolving View Of The Importance Of The Small (Lesser) Saphenous Vein In The Management Of Venous Disease: Is It An Often Neglected Component? | Thomas F. O'Donnell |
| Technique And Results Of Ultrasound Guided Sclerotherapy For Perforator Veins: A Better Simpler Way Than SEPS | Elna M. Masuda |
| Incidence And Significance Of Upper Torso DVT: Does It Lead To Pulmonary Emboli And Is Anticoagulation Indicated? | Fred A. Weaver |
| Debate: Foam Sclerotherapy Will Eliminate Open And Endovascular Therapy For Varicose Veins | John J. Bergan |
| Debate: Foam Sclerotherapy Will Not Eliminate Other Treatments For Varicose Veins: What Are Its Uses? | Jose I. Almeida |
| Panel Discussion |
Session XXII: FOCUS ON NEW OR IMPROVED TECHNOLOGY
| What Is The Real Current Durability Of Conventional Open AAA Repair? Is It Really Better Than That Of EVAR? | Richard P. Cambria |
| Open Surgery For AAA With New Techniques: Is This A Hibernating Or An Extinct Procedure? | Jeffrey L. Ballard, |
| New Developments In Laparoscopic AAA Surgery: What Can It Do That EVAR Cannot And Vice Versa? | Olivier A. Goëau-Brissonnière |
| New Instrumentation And Approaches To Make Laparoscopic Aortic Surgery Easier | Yves S. Alimi |
| A New Stapling Device To Simplify Laparoscopic And Open Aortic Surgery: Why Is It Better Than Others? | Ralf R. Kolvenbach |
| Steerable Arms With Multiple Degrees Of Freedom Of Motion To Facilitate Laparoscopic Aortic Surgery: Do We Really Need A Costly Robot? | Willem Wisselink |
| Panel Discussion | |
| All Studies Relating Natural History And Behavior Of AAAs To CT Size Are Unreliable And Flawed Because Standard CT Measurements Are Inaccurate | George H. Meier |
| In EVAR II Clinicians Scored The Patients Unfit For Open Repair And EVAR Did No Better Than Best Medical Management: However, EVAR Beats Open Repair In "High Risk" Patients | Roger M. Greenhalgh |
| EVAR II May Be Level I Evidence But It May Be Misleading And Should Not Keep Us From Performing EVAR On High Risk Patients | Peter R.F. Bell |
| EVAR On High Risk Patients Is Worthwhile In The US: Nationwide Procedural Mortality Statistics Show The Conclusions Of EVAR II Do Not Apply In The USA | Carlos H. Timaran |
| Is Fenestrated EVAR Appropriate For High Risk Patients? Might EVAR II Be Misleading For Canadian Patients? | Randy D. Moore |
| Limited Open Exposure Techniques To Treat Persistent Type I And II Endoleaks: How To Do Them | Martin R. Back |
| Four-Year Results With The Gore TAG Endograft For TAAs | Michel S. Makaroun |
| Panel Discussion |
Session XXIII: NEW DEVELOPMENTS IN THE TREATMENT OF DISEASES OF THE AORTA AND ITS MAJOR ABDOMINAL BRANCHES
| Is EVAR And Bilateral Hypogastric Artery Interruption – When Necessary – Really So Dangerous? | Armando C. Lobato |
| Branched Grafts For Hypogastric Revascularization: Indications And Contraindications | Eric L.G. Verhoeven |
| Outcomes After Hypogastric Artery Bypass And Embolization With EVAR | W. Anthony Lee |
| Endovascular Treatment Of Visceral Artery Aneurysms: When Is It Feasible, When Not? | Daniel G. Clair |
| Current Endoluminal And Open Treatment Of Peripancreatic (Gastroduodenal, Pancreatico-duodenal And Splenic) Artery Aneurysms | James C. Stanley |
| Retrograde Open Mesenteric Stenting: Advantages In Patients With Acute Mesenteric Ischemia Superimposed On Chronic – And With Dead Bowel | Richard J. Powell |
| Atherosclerotic Renovascular Disease Is More Benign Than We Thought: Data From A Prospective Population Based Study | Kimberley J. Hansen |
| Panel Discussion |
Session XXIV: ISSUES AND UPDATES ON THE ISVS, THE ABVS, THE SVS AND THE PRIMARY CERTIFICATE: PROS AND CONS AND WHERE IS VASCULAR SURGERY GOING
| What Is Happening With The ISVS? Progress Made And Relationship With This Meeting And Other Organizations: Why All Vascular Surgeons And Others Should Join | Peter R.F. Bell |
| How To Meet Current Challenges To Surgical Education In Today’s Unfriendly Environment | Thomas S. Riles |
| Current And Future Roles Of Various SVS Publications And Outlets: The Vascular Web, Vascular Specialist And The JVS – What They Mean For Vascular Surgeons | K. Wayne Johnston |
| What The SVS Is Doing To Define, Protect And Support Vascular Surgery In A Changing World | Enrico Ascher |
| What New Pathways Are Available To Train Vascular Surgeons Under The Primary Certificate? Are They Working And How Many Programs Have Applied? | Jerry Goldstone |
| Why The Primary Certificate In Vascular Surgery Will Fail To Meet The Needs Of The Specialty | Ramon Berguer |
| Status Of The ABVS: Where Do We Go From Here To Gain Independent Board Status? | Robert W. Hobson II |
| Panel Discussion |
Session XXV: LEGAL, BUSINESS AND OTHER ISSUES FOR VASCULAR SURGEONS AND INTERVENTIONALISTS
| Medical Malpractice And The Vascular Surgeon: What Can Be Done To Help Us? | O. William Brown |
| Legal Methods And Strategies To Overcome The Managed Care Monster: How To Level The Playing Field | David A. Manko |
| How To Optimize Vascular Surgery Billing | Sean P. Roddy |
| Present Status Of Vascular Surgery Reimbursement And Prospects For The Future | Robert M. Zwolak |
| A Close-Up View Of Combat Surgery In Iraq: We Owe Our Armed Forces An Enormous Debt Of Gratitude | Stephen F. McCartney |
| Panel Discussion |
Session XXVI: SPECIAL LUNCHEON SESSION ON IMPROVED NEW ENDOGRAFT TECHNOLOGIES
| Features Of An Improved Medtronic Thoracic Endograft: The Valiant Stent-Graft | Ronald M. Fairman | |
| Aortic Arch Replacement: What Is The Next Generation Thoracic Endograft Going To Look Like? | Roy K. Greenberg | |
| Features Of And Early Results With The Endurant Endograft For EVAR: The Next Generation AAA Stent-Graft From Medtronic | Hence J.M. Verhagen | |
| Aorfix™ Endograft: A New More Flexible Stent-Graft For EVAR: Early Clinical Results With Sharply Angulated Neck And Iliac Anatomy | Brian R. Hopkinson | |
| Remodeling Of AAA Morphology 5 Years After EVAR With The Endologix Endograft | Rodney A. White | |
| Laparoscopy And EVAR: There Is A Place For Both | Yves-Marie Dion | |
| Anatomical Characteristics That Make A Patient Suitable For Carotid Stenting And What Percentage Of Patients Fall In This Category: Delphi Consensus |
|
|
| Panel Discussion |
Session XXVII: PHILOSOPHICAL, ETHICAL AND JUDGMENT ISSUES FOR VASCULAR SURGEONS AND INTERVENTIONALISTS
| Ethical Issues Surrounding Live Case Demonstrations: Who Benefits And Who Pays A Price? | Dorothy B. Abel | |
| Judgment Issues In Endovascular Procedures: What Motivates Us And What Should Motivate Us? | Lindsay S. Machan | |
| Prospective Decision Analysis Computer Modeling Indicates Clinical Decisions In Vascular Surgery Often Fail To Maximize Patient Benefit | Thomas E. Brothers | |
|
Session XXVIII: NEW DEVELOPMENTS IN PREVENTION AND TREATMENT OF COMPLICATIONS
| Statin Treatment And EVAR: Do Statins Reduce The Risk Of Cardiovascular Complications? | Jacob Buth |
| Are Prophylactic Antibiotic Regimens For Vascular Surgery Out Of Date In The MRSA Era? What Should Our Current Prophylaxis Be? | Samuel Eric Wilson |
| A New Endovascular Approach For Treating Serous Collections Associated With Prosthetic Arterial Grafts | Nicholas J. Gargiulo |
| VAC-On-Vessel: A New Better Way To Treat Vascular Graft Infections: Why Does It Work So Well? | Dieter O. Mayer |
| New Uses For Deep Vein Grafts: Radical Treatment Of Infected Femoral Pseudoaneurysms, For Femoro-Femoral Bypass, And For Ileorenal And Ileovisceral Artery Bypass With Complex AAAs Treated By EVAR | G. Patrick Clagett |
| Metallic Silver Impregnated Grafts For Use To Treat Infected Prosthetic Grafts By In Situ Replacement In The Infected Field | Max Zegelman |
| Ten-Year Perspective On Procedural And Postprocedural Complications Of Aortic Endografting: Which Complications Remain A Challenge? | Mohan Adiseshiah |
| Can Visual Inspection Of A CT Scan Predict AAA Rupture Risk? Where Does Finite Element Analysis Fit In And What Measurable AAA Characteristics Produce High Areas Of Wall Stress? | David A. Vorp |
Session XXIX: NEW TECHNIQUES AND CONCEPTS WHICH WILL SHAPE OUR FUTURE
| How Vascular Surgeons Should Obtain Exposure For Spine Surgery: Tips, Precautions And Hints For Optimizing Billing | Mark D. Morasch |
| Progress In Myocyte And Stem Cell Transplantation For Inadequate Myocardial Function | Edward B. Diethrich |
| Recent Advances And Potential In Nanotechnology And Biotechnology | Elliot L. Chaikof |
| How Are Simulators Valuable In Teaching Endovascular Techniques? Is There Proof Of Effectiveness? | K. Craig Kent |
| Cook Zenith Flex Endograft: Improved Technological Features With Main Body Diameters Up To 36 mm | Luis A. Sanchez |
| Pharmacological Treatment Of Aneurysms: The Next Horizon | Juan C. Parodi |
| Should AAAs <5.0 - 5.5 cm Be Treated? Do We Know? How Can We Find Out? | Kenneth Ouriel |
| EVAR 5-Year Results With Small vs. Large AAAs: Is Big Really Worse? | Jeffrey P. Carpenter |
| Panel Discussion | |
| Beyond Fusiform And Saccular: Three Dimensional Aortic Shape And Rupture Potential: Does It Correlate With Finite Element Analysis? | Alan Dardik |
| Laparoscopic Guided Endovascular Access To The Aorta And Iliac Vessels | Michael Lawrence-Brown |
| Initial Experience With The VI - Aortounilateral Endograft For AAA | Ralf R. Kolvenbach |
| Phase I US Fenestrated Endograft Trial: The Procedure Can Work In The Real World | Christopher J. Kwolek |
| Techniques And Experience With In Situ Fenestration And Branched Grafts | Richard G. McWilliams |
| Supra-Aortic Revascularization After Thoracic Aneurysm Stent-Grafting By In Situ Fenestration And Endografting Via The Innominate And Carotid Arteries | Ramesh K. Tripathi |
| Instant In Situ Fenestration To Allow Endo Treatment Of Urgent AAAs With Short Necks: Technique And Limitations | Martin Malina |
| Do We Need A New Endograft To Treat Traumatic Aortic Disruption And Why? | Alan B. Lumsden |
| Panel Discussion | |
| Absorbable Polylactic Acid Stents: Clinical Experience, Value And Limitations | Marc Van Sambeek |
| Can Aortobronchial Fistulas Be Treated Successfully By Open Surgery? By Endovascular Means? | Michael J. Jacobs |
| Bone Marrow Stem Cell Injections: Can They Be A Treatment For Critical Ischemia And How Do They Work? | Berthold Amann |
| Does Red Wine Have A Cardiovascular Protective Effect? How Does It Work? | Bauer E. Sumpio |
| EVAR Reduces The Risk Of Rupture Despite Persisting Type I Endoleak: How Can This Possibly Be True? | Christopher K. Zarins |
| The Importance Of Fish Oils: Why All Vascular Patients Should Be On Them, How Do They Work And What Is The Dosage? | William M. Stone |
| The LeMaitre-Endofit Thoracic Endograft: Clinical Trial Update | Dieter Raithel |
| Late Breaking Developments: Interesting New Findings From The SVS Carotid Registry - A Real Step Forward | Anton N. Sidawy |
| Panel Discussion |
Session XXX: RECENT ADVANCES AND UPDATES
| Vascular Challenges After Blunt Trauma To The Thoracic Aorta: Principles In Management And Optimal Techniques For Repair | Kenneth L. Mattox |
| Contemporary Management Of A-V Malformations With A Multidisciplinary Approach | Byung-Boong Lee |
| Why Renal Arteries Get Covered During EVAR: How To Avoid This Mishap | James May |
| Update On The CardioMems Implantable Pressure Sensor For EVAR: Advantages And Limitations | Ross Milner |
| Direct Intrasac Pressure Measurements Of Selected Patients After EVAR Suggest Long-Term Intrasac Pressure Telemetry May Not Replace Conventional Surveillance Imaging Techniques | Martin Malina |
| Tissue Engineered Vascular Grafts: Will They Ever Work? | Bo Risberg |
| Panel Discussion | |
| Treatment Strategies For Type II Endoleaks: How My Thoughts Have Changed | Richard A. Baum |
| What I Have Learned About Type II Endoleaks: How Benign They Are; And How To Detect Them | Kim J. Hodgson |
| The Fate Of Endoleaks Detected By CT But Not Detected By Color Flow Duplex Ultrasonography After EVAR: Can They Be Ignored? | Ali F. AbuRahma |
| Type II Endoleaks Are Not So Benign After All: They Can Produce AAA Rupture Without An Associated Type I Endoleak | David C. Brewster |
| Endovascularly Placed CANCION Device For The Treatment Of Refractory Congestive Heart Failure | Steven F. Bolling |
| Panel Discussion |
Session XXXI: MORE NEW INFORMATION ON ANEURYSMS AND THORACIC AORTIC DISEASE
| DEBATE: With Ruptured AAA, Endo Repair Is Best For Most Patients - Against The Motion | William P. Paaske |
| DEBATE: With Ruptured AAA, Endo Repair Is Best For Most Patients - Against The Motion | Marc R.H.M. van Sambeek |
| DEBATE: With Ruptured AAA, Endo Repair Is Best For Most Patients - For The Motion | Christos D. Liapis |
| The Relay Thoracic Endograft: Technique And Early Results With A New Kind Of Stent-Graft Which Facilitates Easy Precise Placement In A Tortuous Proximal Aortic Arch | Vicente Riambau |
| EUROSTAR Real World Experience With Thoracic Endografts: Is It A Cause For Optimism Or A Cause For Concern? | Peter L. Harris |
| Two- And Three-Dimensional Criteria For Estimating AAA Rupture Risk | Mark F. Fillinger |
| The Need To Include "Best Medical Care In Trials Evaluating Carotid Angioplasty And Stenting" | Anthony J. Comerota |
| The VALOR Trial Of Talent Endografts For A Variety Of Thoracic Aortic Lesions In High Risk Patients: The Real World Experience | Mark A. Farber |
| Debate: IVUS Is The Best Adjunctive Method For Performing Thoracic Endografting: What Are Its Limitations? | Rodney A. White |
| Debate: Transesophageal Echo Is The Best Adjunctive Method For Performing Thoracic Endografting: What Are Its Limitations? | Dietmar H. Koschyk |
| Low Permeability Modifications Of The Gore Excluder And TAG Grafts Affect AAA And TAA Sac Behavior In A Beneficial Way | Thomas C. Naslund |
| Panel Discussion |
Session XXXII: NEW DEVELOPMENTS IN THE MANAGEMENT OF CAROTID, VERTEBRAL AND SUPRA-AORTIC TRUNK DISEASE
| Factors Correlating With Restenosis After CEA: Can They Be Modified And Decrease Restenosis? | Glenn M. LaMuraglia |
| Natural History Of Carotid Artery Occlusion Contralateral To A CEA: It’s More Benign Than We Thought | Ali F. AbuRahma |
| Update On Results Of The CAPTURE Trial: What Does It Mean In The CAS Versus CEA Debate? | Ronald M. Fairman |
| Mini Skin Incision For CEA: A Safe Alternative To The Standard Approach: Indications And Contraindications | Enrico Ascher |
| Vertebral PTA And Stenting With Embolic Protection: How To Do It And Is It Necessary? | Karthikeshwar Kasirajan |
| Is Carotid Plaque Morphology Or Degree Of Stenosis More Important In Determining Prognosis Of An Individual Lesion In Terms Of Natural History; In Terms Of CAS? | Frans L. Moll |
| Intraoperative Imaging After CEA Does Not Improve Outcomes | Caron B. Rockman |
| Tips And Tricks For Managing Carotid Body Tumors | Wesley S. Moore |
| Panel Discussion |
Session XXXIII: OTHER NEW DEVELOPMENTS IN STENTING OF THE CAROTID BIFURCATION AND SUPRA-AORTIC TRUNKS
| When Should We Attempt To Open An Occluded Carotid Or Vertebral Artery? How Should It Be Done? | L. Nelson Hopkins |
| Transcervical Approach To CAS: 3-Year Follow-Up Of 100 Patients: Should It Be A Routine Approach? | Enrique Criado |
| Why Are Randomized Clinical Data The Only Way To Compare The Outcomes Of CAS With Those Of CEA? Do We Yet Have Any Valid Comparative Outcome Results From Anywhere In The Globe? | Robert W. Hobson II |
| Debate: Carotid Stenting Is Ready For General Acceptance And Usage | Mark H. Wholey |
| Debate: Carotid Stenting Is Not Ready For General Acceptance And Usage | Marc Bosiers |
| What Are The Real World Current Stroke And Death Rates For CEA Based On 2 Statewide Studies? How Do They Impact On The Present Role For CAS? | Bruce A. Perler |
| Ischemic Preconditioning To Facilitate Use Of Balloon Embolic Protection (With The PercuSurge Device) When It Is Poorly Tolerated During CAS: How Can This Work And Should The Principle Be Used More Generally? | Peter L. Faries |
| Panel Discussion |
Session XXXIV: UPDATES, NEW CONCEPTS, ADVANCES AND LATE BREAKING TRIALS
| Open Minimally Invasive Limb Salvage Procedures: A Less Morbid Approach | Peter F. Lawrence |
| How To Deal Surgically With A Heavily And Circumferentially Calcified (Porcelain) Aorta | Busquet |
| What Effects Beyond Cholesterol Lowering Do Statin Drugs Have In Vascular Disease Patients? | Ralph G. DePalma |
| What’s New To Facilitate The Endovascular Treatment Of Traumatic Vascular Lesions? | Jan S. Brunkwall |
| Two-Year Results Of The European Superficial Femoral Artery Registry (ESFAR): Lessons Learned | Gerhard Hoffmann |
| Which Graft Is Best For Femorofemoral Bypass - Dacron Or PTFE? Based On Results Of A Randomized Trial In 198 Patients | Torben V. Schroeder |
| Isolated Limb Perfusion With Lytic Drugs Can Improve Limb Salvage After Acute Thromboembolism With Extensive Involvement Of Infrapopliteal Arteries | John F. Eidt |
| Influence Of Real-Time Hemodynamic Monitoring On The Outcome Of EVAR For Ruptured AAAs | J. Adam van der Vliet |
| Vascular Abnormalities In Patients With Neurofibromatosis: What The Vascular Surgeon Needs To Know | Peter Gloviczki |
| Panel Discussion | |
| The Boomerang Device For Closure Of Arterial Punctures: Advantages And Limitations | Ali Amin |
| Is An Iliac Occlusion A Contraindication To EVAR? Techniques To Solve The Problem | William D. Jordan |
| New Methods And Adjuncts To Expand The Indications For EVAR | Jacques Bleyn |
| Optimal Management Of Paget-Schroetter Syndrome: Does Lysis And Conservative Treatment Work And When Is Rib Resection And Stenting Indicated? | Matthew J. Eagleton |
| Complications And Outcomes Associated With Use Of Retrievable IVC Filters: Do The Devices Make A Difference Based On The Collected FDA Data? | Palma M. Shaw |
| Spontaneous Dissection Of The Abdominal Aorta: Clinical Presentation And Best Therapeutic Options: Open Surgical Versus Endovascular | Mark A. Farber |
| Late Breaking Development: Aptus AAA Endograft With Proximal Fixation Staples | David H. Deaton |
| Panel Discussion |
End